Sonoma Pharmaceuticals, Inc. (SNOA) › Shareholders' EquitySonoma Pharmaceuticals, Inc. (SNOA) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2010: $7.04M2011: $1.70M2012: -$868.0K2013: $4.08M2014: $12.06M2015: $12.05M2016: $10.14M2017: $21.43M2018: $15.33M2019: $7.77M2020: $5.62M2021: $5.36M2022: $8.70M2023: $7.98M2024: $6.14M2025: $4.41M2026: $3.10M$3.10M2010Shareholders' Equity (USD)2026Fiscal YearShareholders' EquityChange YoY2026$3.10M-29.8%2025$4.41M-28.1%2024$6.14M-23.1%2023$7.98M-8.3%2022$8.70M+62.2%2021$5.36M-4.6%2020$5.62M-27.6%2019$7.77M-49.3%2018$15.33M-28.5%2017$21.43M+111.4%2016$10.14M-15.9%2015$12.05M-0.1%2014$12.06M+195.6%2013$4.08M+570.2%2012-$868.0K-151.0%2011$1.70M-75.9%2010$7.04M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share